EVONIK OPERATIONS GMBH

EVONIK OPERATIONS GMBH (Germany) holds 3 active US FDA Type II Drug Master Files and 4 inactive, has DMF or CEP filings on record for 6 active ingredients, holds 15 active Type IV (excipient) Drug Master Files and is linked to 6 FDA-registered manufacturing sites. 4 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “EVONIK OPERATIONS GMBH: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/evonik-operations-gmbh

Overview

EVONIK OPERATIONS GMBH is an active pharmaceutical ingredient (API) supplier with 3 active FDA Type II Drug Master Files, covering AZELASTINE HYDROCHLORIDE; LISINOPRIL DIHYDRATE; LORAZEPAM.

Core services & business areas

API ManufacturingPharmaceutical Manufacturing

Active ingredients with DMF or CEP filings

Substances for which EVONIK OPERATIONS GMBH holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

EVONIK OPERATIONS GMBH holds 3 active (7 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • LISINOPRIL DIHYDRATEActive2006-01-26
  • AZELASTINE HYDROCHLORIDEActive2001-05-15
  • LORAZEPAMActive1983-07-09
  • THIAPROLINE-M-AMINOBENZOIC ACID MONOHYDROCHLORIDEInactive2000-09-21
  • NIFEDIPINEInactive1996-04-24
  • CHLORHEXIDINE DIGLUCONATEInactive1990-01-19
  • CHLORHEXIDINE BASEInactive1985-07-02

Excipient Drug Master Files

EVONIK OPERATIONS GMBH holds 15 active (18 total) FDA Type IV Drug Master Files. A Type IV DMF covers an excipient, colourant or flavour, not an active ingredient; these are counted separately from the API filings above.

  • R-DOTMA-CLActive2025-04-30
  • SQUALENEActive2025-03-24
  • EUDRACAP WITH ENTERIC FUNCTIONALITYActive2023-05-17
  • EUDRAGIT IR READYMIXActive2022-05-25
  • EUDRAGIT FL 30 D-55Active2021-12-08
  • EUDRAGIT E PO READYMIXActive2019-02-01
  • EUDRAGIT® EActive2014-03-13
  • EUDRAGIT® L/SActive2014-01-28
  • EUDRAGIT® RL/RSActive2013-05-24
  • RESOMER® R FOR PHARMACEUTICAL APPLICATIONSActive2005-10-28
  • RESOMER® RG FOR PHARMACEUTICAL APPLICATIONSActive2005-10-28
  • EUDRAGIT® FS 30 DActive1999-01-15
  • PLASTOID BActive1996-08-21
  • EUDRAGIT® E 30 D ACRYLATE ESTER COPOLYMER COATINGActive1976-12-23
  • EUDRAGIT® L 30 D-55Active1975-12-19
  • RESOMER® RP D FOR PHARMACEUTICAL APPLICATIONSInactive2010-06-23
  • RESOMER® SR FOR PHARMACEUTICAL APPLICATIONSInactive2010-06-09
  • EUDRAGITSInactive1968-10-02

Registered manufacturing sites (6)

Physical sites registered with the US FDA and resolved to EVONIK OPERATIONS GMBH, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

4 FDA enforcement records linked to this company.

  • 4832014-12-12

    Calibration - at intervals, written program, remedial action

  • 4832014-12-12

    Computer control of master formula records

  • 4832014-12-12

    Lab controls established, including changes

  • 4832014-12-12

    Procedures not in writing, fully followed

For suppliers

Is this EVONIK OPERATIONS GMBH?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.